ID

15838

Beskrivning

Study of MOR209/ES414 in Metastatic Castration-Resistant Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02262910

Länk

https://clinicaltrials.gov/show/NCT02262910

Nyckelord

Versioner (1)
  1. 2016-06-15 2016-06-15 -
Uppladdad den

15 juni 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Prostate Cancer NCT02262910

Engelsk

Eligibility Prostate Cancer NCT02262910

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed adenocarcinoma of the prostate. no evidence of neuroendocrine differentiation or small cell features.
Beskrivning

Adenocarcinoma of prostate | No evidence of Neuroendocrine Differentiation

Datatyp

boolean

Alias
UMLS CUI [1]
C0007112
UMLS CUI [2,1]
C0332125
UMLS CUI [2,2]
C1709218
surgically or medically castrated, with testosterone ≤ 50 ng/dl (≤ 1.7 nmol/l).
Beskrivning

Castration | Medical Castration | Testosterone measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C0007344
UMLS CUI [2]
C1513054
UMLS CUI [3]
C0523912
progressive prostate cancer by either serum psa levels, soft tissue or bone disease as defined by the pcwg2 criteria.
Beskrivning

Prostate carcinoma Progressive | Prostate specific antigen measurement | Disorder of soft tissue | Bone Diseases

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0205329
UMLS CUI [2]
C0201544
UMLS CUI [3]
C0263978
UMLS CUI [4]
C0005940
in stage 1, patients may or may not have received prior chemotherapy for mcrpc. in stage 2, patients will be enrolled into two cohorts based on whether or not they have received prior chemotherapy for mcrpc. any prior chemotherapy must have been completed ≥ 4 weeks prior to administration of es414. additionally, in countries where abiraterone or enzalutamide are commercially available, patients in stage 1 and 2 must have progressed on abiraterone and/or enzalutamide prior to study entry.
Beskrivning

Prior Chemotherapy | Prostatic Cancer, Castration-Resistant Metastatic | abiraterone | enzalutamide

Datatyp

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2,1]
C3658266
UMLS CUI [2,2]
C0036525
UMLS CUI [3]
C0754011
UMLS CUI [4]
C3496793
ecog ≤ 1
Beskrivning

ECOG performance status

Datatyp

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy > 6 months per investigator
Beskrivning

Life Expectancy

Datatyp

boolean

Alias
UMLS CUI [1]
C0023671
adequate hematologic, renal, and hepatic parameters
Beskrivning

Hematologic function | Renal function | Liver function

Datatyp

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232741
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
any chemotherapy or investigational drug in prior 4 weeks
Beskrivning

Chemotherapy | Investigational New Drugs

Datatyp

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0013230
any radiation therapy in prior 2 weeks
Beskrivning

Therapeutic radiology procedure

Datatyp

boolean

Alias
UMLS CUI [1]
C1522449
any prior therapy targeted against psma
Beskrivning

Targeted Therapy Previous Against prostate-specific membrane antigen

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2985566
UMLS CUI [1,2]
C0205156
UMLS CUI [1,3]
C0521124
UMLS CUI [1,4]
C1310550
history of seizures
Beskrivning

Seizures

Datatyp

boolean

Alias
UMLS CUI [1]
C0036572
history of central nervous system metastasis
Beskrivning

CNS metastases

Datatyp

boolean

Alias
UMLS CUI [1]
C0686377
history of nephrotic syndrome
Beskrivning

Nephrotic Syndrome

Datatyp

boolean

Alias
UMLS CUI [1]
C0027726
spot urine total protein:creatinine ratio >1,000 mg/gm
Beskrivning

Urine total protein measurement Spot urine sample | Creatinine measurement, serum | Ratio

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0428541
UMLS CUI [1,2]
C0457208
UMLS CUI [2]
C0201976
UMLS CUI [3]
C0456603
planned palliative procedures for alleviation of bone pain
Beskrivning

Palliative procedure Planned | Bone pain

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1285158
UMLS CUI [1,2]
C1301732
UMLS CUI [2]
C0151825
active infection requiring treatment with systemic anti-infectives or major surgery in prior 4 weeks.
Beskrivning

Communicable Diseases | Therapeutic procedure Anti-Infective Agents Systemic | major surgery

Datatyp

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0003204
UMLS CUI [2,3]
C0205373
UMLS CUI [3]
C0679637
any prednisone (or equivalent corticosteroids) use within 4 weeks of study entry
Beskrivning

Prednisone | Adrenal Cortex Hormones equivalent

Datatyp

boolean

Alias
UMLS CUI [1]
C0032952
UMLS CUI [2,1]
C0001617
UMLS CUI [2,2]
C3242703
chronic immunosuppressive therapy
Beskrivning

Therapeutic immunosuppression chronic

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0021079
UMLS CUI [1,2]
C0205191
known history of hiv, hepatitis b, or hepatitis c infection
Beskrivning

HIV | Hepatitis B | Hepatitis C

Datatyp

boolean

Alias
UMLS CUI [1]
C0019682
UMLS CUI [2]
C0019163
UMLS CUI [3]
C0019196
evidence of severe or uncontrolled systemic diseases
Beskrivning

Systemic disease Severe | Systemic disease Uncontrolled

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0442893
UMLS CUI [2,2]
C0205318
history of bleeding disorders or thromboembolic events in prior 3 months
Beskrivning

Blood Coagulation Disorders | Thromboembolism

Datatyp

boolean

Alias
UMLS CUI [1]
C0005779
UMLS CUI [2]
C0040038
Tillbaka till toppen

Similar models

Eligibility Prostate Cancer NCT02262910

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of prostate | No evidence of Neuroendocrine Differentiation
Item
histologically or cytologically confirmed adenocarcinoma of the prostate. no evidence of neuroendocrine differentiation or small cell features.
boolean
C0007112 (UMLS CUI [1])
C0332125 (UMLS CUI [2,1])
C1709218 (UMLS CUI [2,2])
Castration | Medical Castration | Testosterone measurement
Item
surgically or medically castrated, with testosterone ≤ 50 ng/dl (≤ 1.7 nmol/l).
boolean
C0007344 (UMLS CUI [1])
C1513054 (UMLS CUI [2])
C0523912 (UMLS CUI [3])
Prostate carcinoma Progressive | Prostate specific antigen measurement | Disorder of soft tissue | Bone Diseases
Item
progressive prostate cancer by either serum psa levels, soft tissue or bone disease as defined by the pcwg2 criteria.
boolean
C0600139 (UMLS CUI [1,1])
C0205329 (UMLS CUI [1,2])
C0201544 (UMLS CUI [2])
C0263978 (UMLS CUI [3])
C0005940 (UMLS CUI [4])
Prior Chemotherapy | Prostatic Cancer, Castration-Resistant Metastatic | abiraterone | enzalutamide
Item
in stage 1, patients may or may not have received prior chemotherapy for mcrpc. in stage 2, patients will be enrolled into two cohorts based on whether or not they have received prior chemotherapy for mcrpc. any prior chemotherapy must have been completed ≥ 4 weeks prior to administration of es414. additionally, in countries where abiraterone or enzalutamide are commercially available, patients in stage 1 and 2 must have progressed on abiraterone and/or enzalutamide prior to study entry.
boolean
C1514457 (UMLS CUI [1])
C3658266 (UMLS CUI [2,1])
C0036525 (UMLS CUI [2,2])
C0754011 (UMLS CUI [3])
C3496793 (UMLS CUI [4])
ECOG performance status
Item
ecog ≤ 1
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy > 6 months per investigator
boolean
C0023671 (UMLS CUI [1])
Hematologic function | Renal function | Liver function
Item
adequate hematologic, renal, and hepatic parameters
boolean
C0221130 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Chemotherapy | Investigational New Drugs
Item
any chemotherapy or investigational drug in prior 4 weeks
boolean
C0392920 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Therapeutic radiology procedure
Item
any radiation therapy in prior 2 weeks
boolean
C1522449 (UMLS CUI [1])
Targeted Therapy Previous Against prostate-specific membrane antigen
Item
any prior therapy targeted against psma
boolean
C2985566 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0521124 (UMLS CUI [1,3])
C1310550 (UMLS CUI [1,4])
Seizures
Item
history of seizures
boolean
C0036572 (UMLS CUI [1])
CNS metastases
Item
history of central nervous system metastasis
boolean
C0686377 (UMLS CUI [1])
Nephrotic Syndrome
Item
history of nephrotic syndrome
boolean
C0027726 (UMLS CUI [1])
Urine total protein measurement Spot urine sample | Creatinine measurement, serum | Ratio
Item
spot urine total protein:creatinine ratio >1,000 mg/gm
boolean
C0428541 (UMLS CUI [1,1])
C0457208 (UMLS CUI [1,2])
C0201976 (UMLS CUI [2])
C0456603 (UMLS CUI [3])
Palliative procedure Planned | Bone pain
Item
planned palliative procedures for alleviation of bone pain
boolean
C1285158 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C0151825 (UMLS CUI [2])
Communicable Diseases | Therapeutic procedure Anti-Infective Agents Systemic | major surgery
Item
active infection requiring treatment with systemic anti-infectives or major surgery in prior 4 weeks.
boolean
C0009450 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0003204 (UMLS CUI [2,2])
C0205373 (UMLS CUI [2,3])
C0679637 (UMLS CUI [3])
Prednisone | Adrenal Cortex Hormones equivalent
Item
any prednisone (or equivalent corticosteroids) use within 4 weeks of study entry
boolean
C0032952 (UMLS CUI [1])
C0001617 (UMLS CUI [2,1])
C3242703 (UMLS CUI [2,2])
Therapeutic immunosuppression chronic
Item
chronic immunosuppressive therapy
boolean
C0021079 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
HIV | Hepatitis B | Hepatitis C
Item
known history of hiv, hepatitis b, or hepatitis c infection
boolean
C0019682 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
Systemic disease Severe | Systemic disease Uncontrolled
Item
evidence of severe or uncontrolled systemic diseases
boolean
C0442893 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0442893 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Blood Coagulation Disorders | Thromboembolism
Item
history of bleeding disorders or thromboembolic events in prior 3 months
boolean
C0005779 (UMLS CUI [1])
C0040038 (UMLS CUI [2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial